Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lantheus
Biotech
ESMO: Lantheus' radiotherapy readout not enough to best Pluvicto
Lantheus may have been hoping that “statistically significant” data for its radioligand therapy would make a splash, but not everyone is impressed.
James Waldron
Sep 16, 2024 8:55am
Lantheus acquires Alzheimer’s PET diagnostic developer Meilleur
Jul 15, 2024 11:30am
Atai, Eli Lilly, Novartis & more—Chutes & Ladders
May 17, 2024 8:30am
Lantheus nabs Cerveau and its tau PET tracer for Alzheimer's
Feb 8, 2023 11:12am
Lantheus pledges up to $2B for 2 of POINT's radiopharmaceuticals
Nov 14, 2022 9:50am
Lantheus to buy Progenics to chase cancer diagnostics and drugs
Oct 2, 2019 10:57am
